Homocysteine and prevention of cardiovascular diseases in the elderly;Homocystéine et prévention cardiovasculaire chez le sujet âgé

Annales de Biologie Clinique

Volumn 59, Issue 4, 2001, Pages 465-468

  Demuth, K ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BIOLOGICAL MARKER; CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE; MECOBALAMIN; METHIONINE SYNTHASE; PYRIDOXINE; VITAMIN;

AGED; AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; HUMAN; HYPERHOMOCYSTEINEMIA; METABOLISM; REVIEW; RISK FACTOR;

AGED; AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HOMOCYSTEINE; HUMANS; RISK FACTORS;

EID: 0034922750     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia
2. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
3. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease
4. Blood levels of homocysteine and increased risks of cardiovascular disease
5. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
6. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial
7. Prevention conference V. Beyond secondary prevention: Identifying the high-risk patient for primary prevention. Executive summary
8. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
9. Hyperhomocysteinemia in high-aged subjects: Relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation
10. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease
11. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women
12. The significance of subnormal serum vitamin B12 concentration in the elderly. A case-control study
13. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for sociopsychological performance in a psychogeriatric population
14. Role of homocysteine in age-related vascular and non-vascular diseases